- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00735865
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion
Study Overview
Status
Conditions
Detailed Description
This study will investigate the impact of punctal occlusion on the ocular microbial flora. Current thought is that punctal occlusion causes retention of inflammatory mediators on the ocular surface which may produce pathology, we hypothesize that blockage of the nasolacrimal drainage system may allow colonization of the ocular surface by potentially pathogenic ubiquitous organisms (which may produce exotoxins and other biologic products) that may be responsible for signs and symptoms seen in some patients. Additionally, the presence of the silicone foreign body(punctal plug) may act as a nidus for bacterial adhesion with biofilm production (which is known to occur with Pseudomonas sp and other organisms). There would thus be a paradigm shift of our current understanding of the pathophysiology of punctal occlusion. Additionally, the choice of antimicrobials for the treatment of infections in patients with punctal occlusion may need to be modified if the microbial flora is found to be different in patients with punctal occlusion.
The ocular flora may be different inpatients with severe dry eye or other chronic pathologic conditions, which are frequent indications for punctal occlusion. However, from our retrospective review, we could not determine if there was a change in the microbial flora following plug placement with colonization with these "unusual organisms" since baseline cultures prior to punctal plug placement were not obtained.
We will try to differentiate any effect on the microbial flora caused by the silicone plug or acrylic plug(as a foreign body) versus the punctal closure by thermocautery. (Punctal thermocauterization is an alternative method of punctal closure which is 1) the preferred choice by some ophthalmologists for all their cases, or 2) when the dry eye is severe and irreversible punctal occlusion is desired or 3) if punctal plugs can not be retained due to the large size of the patients punctal). The thermodynamic hydrophobic acrylic plug(SmartPLUG) approved by the FDA for punctal occlusion with the same indications as the traditional silicone plug.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Burlington, Massachusetts, United States, 01805
- Lahey Clinic, Inc.
-
Peabody, Massachusetts, United States, 01960
- Lahey Clinic North
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years and older
- Able to sign Informed Consent
- Clinical indication for punctal plug insertion or punctal cautery or symptomatic patients who have previously had punctal occlusion
- Clinical indication for punctal plug removal(Partial extrusion, discomfort) increased signs of ocular irritation with punctate keratopathy, punctal inflammation).
- Able to make follow up visit schedule
Exclusion Criteria:
- Subjects without dry eye
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 2
|
Up to 5 subjects. Subjects in need of punctal occlusion(No preference for punctal thermocauterization or punctal occlusion by silicone plug). Randomize one eye to silicone punctal plug occlusion, the other eye to punctal thermocauterization. This group ONLY, cultures will be obtained of the lid margin & conjunctiva/inferior fornix of BOTH eyes |
|
Active Comparator: 1
|
25 subjects(20 silicone punctal plugs, 5 punctal cautery) The procedure will be based on clinical indication.
Randomized one eye for study.
Baseline cultures of lid margin & tarsal/inferior fornix conjunctiva obtained & plated according to protocol
|
|
Active Comparator: 3
|
Up to 5 subjects. Subjects in need of punctal occlusion(not preference for punctal occlusion by silicone plug or by the thermodynamic hydrophobic acrylic plug). Randomize one eye to silicone punctal plug occlusion, the other eye to acrylic punctal plug occlusion. In this group ONLY cultures will be obtained of the lid margin and conjunctiva/inferior fornix of BOTH eyes |
|
Active Comparator: 4
|
Up to 20 subjects(15 subjects with silicone punctal plug closure and 5 subjects with punctal closure by thermocauterization)Subjects who have previously had punctal occlusion who have symptoms and/or signs thought to be secondary to punctal occlusion. Lid margin and conjunctiva/inferior fornix of eye with greatest sign or symptoms will be cultured/plated according to standard protocol. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Impact of punctal occlusion on the ocular microbial flora
Time Frame: 1 year(3mo, 6mo, 12 mo culture/follow up visits)
|
1 year(3mo, 6mo, 12 mo culture/follow up visits)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sarkis H. Soukiasian, M.D., Lahey Clinic, Inc.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2003-049
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye Syndrome
-
Applied Science & Performance InstituteTrue Eye Experts - New Tampa; True Eye Experts - Lutz; True Eye Experts - South...CompletedDry Eye | Dry Eye SyndromesUnited States
-
Universiti Sains MalaysiaNot yet recruitingDry Eye Disease (DED) | Dry Eye Symptoms | Dry Eye Syndrome (DES)Malaysia
-
Pleryon Therapeutics (Hangzhou) LimitedUniversity of Waterloo School of Optometry and Vision ScienceRecruiting
-
University Hospital, LimogesCompleted
-
University of AlicantePharmactive Biotech Products S.L.UWithdrawn
-
The General Authority for Teaching Hospitals and...Recruiting
-
Huons Co., Ltd.CompletedDry Eye SyndromesSouth Korea
-
BRIM Biotechnology Inc.ORA, Inc.Completed
-
BRIM Biotechnology Inc.Completed
-
Laboratoires TheaCompletedDry Eye SyndromeHungary, Czechia
Clinical Trials on Punctal plugs, punctal cautery
-
Tanta UniversityCompleted
-
Rabin Medical CenterAlpha Net Co. Ltd.CompletedConjunctivitis | EpiphoraIsrael
-
Mati Therapeutics Inc.CompletedDry Eye SyndromesUnited States
-
AllerganCompleted
-
Queen's UniversityCompleted
-
Universidad Autonoma de Nuevo LeonRecruitingDED | Aqueous-deficient Dry Eye DiseaseMexico
-
Rabin Medical CenterUnknownContact Lens and Punctal Plug in Preventing Corneal InjuriesIsrael
-
University of New MexicoWithdrawn
-
University of OklahomaCompletedDry Eye | Dry Eye Syndromes | Ocular Surface DiseaseUnited States
-
Mati Therapeutics Inc.CompletedOcular Hypertension | Open-Angle GlaucomaUnited States